Abstract
Postmenopausal bleeding is the most common symptom of endometrial cancer and always requires work-up. If a woman is using sequential hormone therapy, she may have monthly bleeding, which is expected. Most postmenopausal women using hormone therapy are on continuous regimens and do not have vaginal bleeding. The risk of endometrial cancer is reduced, but not absent, with the addition of progesterone.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sherif, K. (2013). FAQ: Evaluation of Abnormal Menstrual Bleeding. In: Hormone Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6268-2_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6268-2_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6267-5
Online ISBN: 978-1-4614-6268-2
eBook Packages: MedicineMedicine (R0)